{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T07:48:27Z","timestamp":1790754507577,"version":"4.1.0"},"reference-count":83,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2020,10,29]],"date-time":"2020-10-29T00:00:00Z","timestamp":1603929600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,10,29]],"date-time":"2020-10-29T00:00:00Z","timestamp":1603929600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Hypertens Rep"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1007\/s11906-020-01106-5","type":"journal-article","created":{"date-parts":[[2020,10,29]],"date-time":"2020-10-29T13:02:33Z","timestamp":1603976553000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["What Is the Most Common Cause of Secondary Hypertension?: An Interdisciplinary Discussion"],"prefix":"10.1007","volume":"22","author":[{"given":"Madson Q.","family":"Almeida","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanio V.","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciano F.","family":"Drager","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,29]]},"reference":[{"issue":"3 Suppl 3","key":"1106_CR1","first-page":"67","volume":"107","author":"MVB Malachias","year":"2016","unstructured":"Malachias MVB, Bortolotto LA, Drager LF, Borelli FAO, Lotaif LAD, Martins LC. 7th Brazilian Guideline of arterial hypertension: chapter 12-secondary arterial hypertension. Arq Bras Cardiol. 2016;107(3 Suppl 3):67\u201374.","journal-title":"Arq Bras Cardiol"},{"issue":"6","key":"1106_CR2","first-page":"e140","volume":"71","author":"PK Whelton","year":"2018","unstructured":"Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice guidelines. Hypertension. 2018 Jun;71(6):e13-e115. Erratum in: Hypertension. 2018;71(6):e140\u20134.","journal-title":"Erratum in: Hypertension"},{"issue":"33","key":"1106_CR3","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1093\/eurheartj\/ehy339","volume":"39","author":"B Williams","year":"2018","unstructured":"Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, et al. ESC Scientific Document Group. 2018 ESC\/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018;39(33):3021\u2013104.","journal-title":"Eur Heart J"},{"issue":"5","key":"1106_CR4","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1161\/HYPERTENSIONAHA.111.179788","volume":"58","author":"RP Pedrosa","year":"2011","unstructured":"Pedrosa RP, Drager LF, Gonzaga CC, Sousa MG, de Paula LK, Amaro AC, et al. Obstructive sleep apnea: the most common secondary cause of hypertension associated with resistant hypertension. Hypertension. 2011;58(5):811\u20137.","journal-title":"Hypertension."},{"issue":"11","key":"1106_CR5","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/jhh.2013.32","volume":"27","author":"E Florczak","year":"2013","unstructured":"Florczak E, Prejbisz A, Szwench-Pietrasz E, Sliwi\u0144ski P, Biele\u0144 P, Klisiewicz A, et al. Clinical characteristics of patients with resistant hypertension: the RESIST-POL study. J Hum Hypertens. 2013;27(11):678\u201385.","journal-title":"J Hum Hypertens"},{"key":"1106_CR6","first-page":"295","volume":"58","author":"AB Hill","year":"1965","unstructured":"Hill AB. The environment and disease: association or causation? Proc R Soc Med. 1965;58:295\u2013300.","journal-title":"Proc R Soc Med"},{"issue":"12","key":"1106_CR7","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1136\/jech.55.12.905","volume":"55","author":"M Parascandola","year":"2001","unstructured":"Parascandola M, Weed DL. Causation in epidemiology. J Epidemiol Community Health. 2001;55(12):905\u201312.","journal-title":"J Epidemiol Community Health"},{"issue":"5","key":"1106_CR8","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1210\/jc.2015-4061","volume":"101","author":"JW Funder","year":"2016","unstructured":"Funder JW, Carey RM, Mantero F, Murad MH, Reincke M, Shibata H, et al. The management of primary aldosteronism: case detection, diagnosis, and treatment: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2016;101(5):1889\u2013916.","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"1106_CR9","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.jacc.2005.01.015","volume":"45","author":"P Milliez","year":"2005","unstructured":"Milliez P, Girerd X, Plouin PF, Blacher J, Safar ME, Mourad JJ. Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism. J Am Coll Cardiol. 2005;45(8):1243\u20138.","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"1106_CR10","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1161\/HYPERTENSIONAHA.113.01060","volume":"62","author":"S Savard","year":"2013","unstructured":"Savard S, Amar L, Plouin PF, Steichen O. Cardiovascular complications associated with primary aldosteronism: a controlled cross-sectional study. Hypertension. 2013;62(2):331\u20136.","journal-title":"Hypertension."},{"issue":"1","key":"1106_CR11","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S2213-8587(17)30319-4","volume":"6","author":"S Monticone","year":"2018","unstructured":"Monticone S, D\u2019Ascenzo F, Moretti C, Williams TA, Veglio F, Gaita F, et al. Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a systematic review and meta-analysis. Lancet Diabetes Endocrinol. 2018;6(1):41\u201350.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"11","key":"1106_CR12","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1016\/j.jacc.2006.07.059","volume":"48","author":"GP Rossi","year":"2006","unstructured":"Rossi GP, Bernini G, Caliumi C, Desideri G, Fabris B, Ferri C, et al. A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients. J Am Coll Cardiol. 2006;48(11):2293\u2013300.","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"1106_CR13","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1590\/2359-3997000000274","volume":"61","author":"LAP Vilela","year":"2017","unstructured":"Vilela LAP, Almeida MQ. Diagnosis and management of primary aldosteronism. Arch Endocrinol Metab. 2017;61(3):305\u201312.","journal-title":"Arch Endocrinol Metab"},{"issue":"8","key":"1106_CR14","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.1210\/jc.2013-4146","volume":"99","author":"V Lim","year":"2014","unstructured":"Lim V, Guo Q, Grant CS, Thompson GB, Richards ML, Farley DR, et al. Accuracy of adrenal imaging and adrenal venous sampling in predicting surgical cure of primary aldosteronism. J Clin Endocrinol Metab. 2014;99(8):2712\u20139.","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"1106_CR15","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S2213-8587(16)30100-0","volume":"4","author":"T Dekkers","year":"2016","unstructured":"Dekkers T, Prejbisz A, Kool LJ, Groenewoud HJ, Velema M, Spiering W, et al. Adrenal vein sampling versus CT scan to determine treatment in primary aldosteronism: an outcome-based randomised diagnostic trial. Lancet Diabetes Endocrinol. 2016;4(9):739\u201346.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"5","key":"1106_CR16","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1161\/HYPERTENSIONAHA.108.111369","volume":"51","author":"GP Rossi","year":"2008","unstructured":"Rossi GP, Bolognesi M, Rizzoni D, Seccia TM, Piva A, Porteri E, et al. Vascular remodeling and duration of hypertension predict outcome of adrenalectomy in primary aldosteronism patients. Hypertension. 2008;51(5):1366\u201371.","journal-title":"Hypertension."},{"issue":"5","key":"1106_CR17","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1161\/HYPERTENSIONAHA.107.095448","volume":"50","author":"C Catena","year":"2007","unstructured":"Catena C, Colussi G, Lapenna R, Nadalini E, Chiuch A, Gianfagna P, et al. Long-term cardiac effects of adrenalectomy or mineralocorticoid antagonists in patients with primary aldosteronism. Hypertension. 2007;50(5):911\u20138.","journal-title":"Hypertension."},{"issue":"1","key":"1106_CR18","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1161\/HYPERTENSIONAHA.113.01316","volume":"62","author":"GP Rossi","year":"2013","unstructured":"Rossi GP, Cesari M, Cuspidi C, Maiolino G, Cicala MV, Bisogni V, et al. Long-term control of arterial hypertension and regression of left ventricular hypertrophy with treatment of primary aldosteronism. Hypertension. 2013;62(1):62\u20139.","journal-title":"Hypertension."},{"issue":"3","key":"1106_CR19","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1210\/jc.2009-1763","volume":"95","author":"N Sukor","year":"2010","unstructured":"Sukor N, Kogovsek C, Gordon RD, Robson D, Stowasser M. Improved quality of life, blood pressure, and biochemical status following laparoscopic adrenalectomy for unilateral primary aldosteronism. J Clin Endocrinol Metab. 2010;95(3):1360\u20134.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"1106_CR20","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s00268-004-7496-z","volume":"29","author":"A Meyer","year":"2005","unstructured":"Meyer A, Brabant G, Behrend M. Long-term follow-up after adrenalectomy for primary aldosteronism. World J Surg. 2005;29(2):155\u20139.","journal-title":"World J Surg"},{"issue":"4","key":"1106_CR21","doi-asserted-by":"crossref","first-page":"258","DOI":"10.7326\/0003-4819-135-4-200108210-00010","volume":"135","author":"AM Sawka","year":"2001","unstructured":"Sawka AM, Young WF, Thompson GB, Grant CS, Farley DR, Leibson C, et al. Primary aldosteronism: factors associated with normalization of blood pressure after surgery. Ann Intern Med. 2001;135(4):258\u201361.","journal-title":"Ann Intern Med"},{"key":"1106_CR22","doi-asserted-by":"crossref","unstructured":"\u2022\u2022 Vilela LAP, Rassi-Cruz M, Guimaraes AG, CCS M, Freitas TC, Alencar NP, et al. KCNJ5 somatic mutation is a predictor of hypertension remission after adrenalectomy for unilateral primary aldosteronism. The Journal of clinical endocrinology and metabolism. J Clin Endocrinol Metab. 2019;104(10):4695\u2013702 A KCNJ5 somatic mutation was an independent predictor of hypertension remission after unilateral adrenalectomy in patients with unilateral PA.","DOI":"10.1210\/jc.2019-00531"},{"issue":"1","key":"1106_CR23","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S2213-8587(17)30367-4","volume":"6","author":"GL Hundemer","year":"2018","unstructured":"\u2022\u2022 Hundemer GL, Curhan GC, Yozamp N, Wang M, Vaidya A. Cardiometabolic outcomes and mortality in medically treated primary aldosteronism: a retrospective cohort study. Lancet Diabetes Endocrinol. 2018;6(1):51\u20139 Besides normalizing blood pressure and hypokalemia, the main goal of medical treatment should be increase renin levels.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"6","key":"1106_CR24","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1210\/jc.2014-1498","volume":"99","author":"JW Lenders","year":"2014","unstructured":"Lenders JW, Duh QY, Eisenhofer G, Gimenez-Roqueplo AP, Grebe SK, Murad MH, et al. Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2014;99(6):1915\u201342.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"1106_CR25","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.jmoldx.2017.04.009","volume":"19","author":"M Curras-Freixes","year":"2017","unstructured":"Curras-Freixes M, Pineiro-Yanez E, Montero-Conde C, Apellaniz-Ruiz M, Calsina B, Mancikova V, et al. PheoSeq: a targeted next-generation sequencing assay for pheochromocytoma and paraganglioma diagnostics. J Mol Diagn. 2017;19(4):575\u201388.","journal-title":"J Mol Diagn"},{"issue":"2","key":"1106_CR26","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ccell.2017.01.001","volume":"31","author":"L Fishbein","year":"2017","unstructured":"Fishbein L, Leshchiner I, Walter V, Danilova L, Robertson AG, Johnson AR, et al. Comprehensive molecular characterization of pheochromocytoma and paraganglioma. Cancer Cell. 2017;31(2):181\u201393.","journal-title":"Cancer Cell"},{"issue":"4","key":"1106_CR27","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1210\/jc.2016-3829","volume":"102","author":"C Pamporaki","year":"2017","unstructured":"Pamporaki C, Hamplova B, Peitzsch M, Prejbisz A, Beuschlein F, Timmers H, et al. Characteristics of pediatric vs adult pheochromocytomas and paragangliomas. J Clin Endocrinol Metab. 2017;102(4):1122\u201332.","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"1106_CR28","doi-asserted-by":"crossref","first-page":"4069","DOI":"10.1210\/jc.2007-1720","volume":"92","author":"K Pacak","year":"2007","unstructured":"Pacak K. Preoperative management of the pheochromocytoma patient. J Clin Endocrinol Metab. 2007;92(11):4069\u201379.","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"1106_CR29","first-page":"1026","volume":"78","author":"I Klein","year":"1994","unstructured":"Klein I, Ojamaa K. Thyroid hormone and the cardiovascular system: from theory to practice. J Clin Endocrinol Metab. 1994;78(5):1026\u20137.","journal-title":"J Clin Endocrinol Metab"},{"issue":"15","key":"1106_CR30","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1001\/archinte.164.15.1675","volume":"164","author":"L Frost","year":"2004","unstructured":"Frost L, Vestergaard P, Mosekilde L. Hyperthyroidism and risk of atrial fibrillation or flutter: a population-based study. Arch Intern Med. 2004;164(15):1675\u20138.","journal-title":"Arch Intern Med"},{"issue":"7","key":"1106_CR31","doi-asserted-by":"crossref","first-page":"401","DOI":"10.11622\/smedj.2013142","volume":"54","author":"WX Jian","year":"2013","unstructured":"Jian WX, Jin J, Qin L, Fang WJ, Chen XR, Chen HB, et al. Relationship between thyroid-stimulating hormone and blood pressure in the middle-aged and elderly population. Singap Med J. 2013;54(7):401\u20135.","journal-title":"Singap Med J"},{"issue":"7","key":"1106_CR32","first-page":"453","volume":"96","author":"L Charles","year":"2017","unstructured":"\u2022\u2022 Charles L, Triscott J, Dobbs B. Secondary hypertension: discovering the underlying cause. Am Fam Physician. 2017;96(7):453\u201361 Nice review of prevalence of secondary hypertension, highlighting the different prevalence of diseases according to age group.","journal-title":"Am Fam Physician"},{"key":"1106_CR33","unstructured":"Preston RA, Epstein M. Renal parenchymal disease and hypertension. Semin. Nephrol. 1995 Mar;15(2):138\u201351."},{"key":"1106_CR34","doi-asserted-by":"crossref","unstructured":"Ritz E. Hypertension: the kidney is the culprit even in the absence of kidney disease. Kidney Int. 2007;71(5):371\u20132.","DOI":"10.1038\/sj.ki.5002142"},{"issue":"5","key":"1106_CR35","doi-asserted-by":"crossref","first-page":"e53","DOI":"10.1161\/HYP.0000000000000084","volume":"72","author":"RM Carey","year":"2018","unstructured":"Carey RM, Calhoun DA, Bakris GL, Brook RD, Daugherty SL, Dennison-Himmelfarb CR, et al. Resistant hypertension: detection, evaluation, and management: a scientific statement from the American Heart Association. Hypertension. 2018;72(5):e53\u201390.","journal-title":"Hypertension"},{"issue":"4","key":"1106_CR36","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1097\/01.mnh.0000450777.17698.8e","volume":"23","author":"AC Pao","year":"2014","unstructured":"Pao AC. Update on the Guytonian view of hypertension. Curr Opin Nephrol Hypertens. 2014 Jul;23(4):391\u20138.","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"1106_CR37","doi-asserted-by":"crossref","unstructured":"Ridao N, Lu\u00f1o J, Garc\u00eda de Vinuesa S, G\u00f3mez F, Tejedor A, Valderr\u00e1bano F. Prevalence of hypertension in renal disease. Nephrol Dial 604 Transplant. 2001;16(Suppl 1):70\u20133.","DOI":"10.1093\/ndt\/16.suppl_1.70"},{"key":"1106_CR38","doi-asserted-by":"crossref","unstructured":"Bergmann C, Guay-Woodford LM, Harris PC, Horie S, Peters DJM, Torres VE. Polycystic kidney disease. Nat Rev Dis Primers. 2018;4(1):50.","DOI":"10.1038\/s41572-018-0047-y"},{"issue":"2","key":"1106_CR39","doi-asserted-by":"crossref","first-page":"41","DOI":"10.5049\/EBP.2015.13.2.41","volume":"13","author":"CG Ihm","year":"2015","unstructured":"Ihm CG. Hypertension in chronic glomerulonephritis. Electrolyte Blood Press. 2015;13(2):41\u20135.","journal-title":"Electrolyte Blood Press"},{"issue":"4","key":"1106_CR40","doi-asserted-by":"crossref","first-page":"258","DOI":"10.7326\/M14-0488","volume":"162","author":"AH Anderson","year":"2015","unstructured":"Anderson AH, Yang W, Townsend RR, Pan Q, Chertow GM, Kusek JW, et al. Time-updated systolic blood pressure and the progression of chronic kidney disease: a cohort study. Ann Intern Med. 2015;162(4):258\u201365.","journal-title":"Ann Intern Med"},{"issue":"1","key":"1106_CR41","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.mcna.2016.08.010","volume":"101","author":"SC Textor","year":"2017","unstructured":"\u2022\u2022 Textor SC. Renal arterial disease and hypertension. Med Clin North Am. 2017;101(1):65\u201379 Rational approach to managing renovascular hypertension in the current era.","journal-title":"Med Clin North Am."},{"key":"1106_CR42","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/5584_2016_89","volume":"956","author":"R Schoepe","year":"2017","unstructured":"Schoepe R, McQuillan S, Valsan D, Teehan G. Atherosclerotic renal artery stenosis. Adv Exp Med Biol. 2017;956:209\u201313.","journal-title":"Adv Exp Med Biol"},{"issue":"2","key":"1106_CR43","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/ajh\/hpx154","volume":"31","author":"SM Herrmann","year":"2018","unstructured":"Herrmann SM, Textor SC. Current concepts in the treatment of renovascular hypertension. Am J Hypertens. 2018 Jan 12;31(2):139\u201349.","journal-title":"Am J Hypertens"},{"issue":"20","key":"1106_CR44","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1056\/NEJMoa0905368","volume":"361","author":"ASTRAL Investigators","year":"2009","unstructured":"Investigators ASTRAL, Wheatley K, Ives N, Gray R, Kalra PA, Moss JG, et al. Revascularization versus medical therapy for renal-artery stenosis. N Engl J Med. 2009 Nov 12;361(20):1953\u201362.","journal-title":"N Engl J Med"},{"issue":"1","key":"1106_CR45","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1056\/NEJMoa1310753","volume":"370","author":"CJ Cooper","year":"2014","unstructured":"Cooper CJ, Murphy TP, Cutlip DE, Jamerson K, Henrich W, Reid DM, et al. Stenting and medical therapy for atherosclerotic renal-artery stenosis. N Engl J Med. 2014;370(1):13\u201322.","journal-title":"N Engl J Med"},{"issue":"6","key":"1106_CR46","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.jcin.2018.10.023","volume":"12","author":"M Prince","year":"2019","unstructured":"Prince M, Tafur JD, White CJ. When and how should we revascularize patients with atherosclerotic renal artery stenosis? JACC Cardiovasc Interv. 2019;12(6):505\u201317.","journal-title":"JACC Cardiovasc Interv"},{"issue":"11 Suppl 2","key":"1106_CR47","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.3949\/ccjm.83.s2.06","volume":"83","author":"EK Brinza","year":"2016","unstructured":"Brinza EK, Gornik HL. Fibromuscular dysplasia: advances in understanding and management. Cleve Clin J Med. 2016;83(11 Suppl 2):S45\u201351.","journal-title":"Cleve Clin J Med"},{"issue":"7","key":"1106_CR48","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.jacc.2013.05.045","volume":"62","author":"LF Drager","year":"2013","unstructured":"Drager LF, Togeiro SM, Polotsky VY, Lorenzi-Filho G. Obstructive sleep apnea: a cardiometabolic risk in obesity and the metabolic syndrome. J Am Coll Cardiol. 2013;62(7):569\u201376.","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"1106_CR49","doi-asserted-by":"crossref","first-page":"H1101","DOI":"10.1152\/ajpheart.00094.2015","volume":"309","author":"LF Drager","year":"2015","unstructured":"Drager LF, Polotsky VY, O\u2019Donnell CP, Cravo SL, Lorenzi-Filho G, Machado BH. Translational approaches to understanding metabolic dysfunction and cardiovascular consequences of obstructive sleep apnea. Am J Physiol Heart Circ Physiol. 2015;309(7):H1101\u201311.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"5","key":"1106_CR50","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.sleep.2009.10.005","volume":"11","author":"S Tufik","year":"2010","unstructured":"Tufik S, Santos-Silva R, Taddei JA, Bittencourt LR. Obstructive sleep apnea syndrome in the Sao Paulo Epidemiologic Sleep Study. Sleep Med. 2010;11(5):441\u20136.","journal-title":"Sleep Med"},{"issue":"6","key":"1106_CR51","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1016\/j.chest.2018.12.003","volume":"155","author":"LF Drager","year":"2019","unstructured":"Drager LF, Santos RB, Silva WA, Parise BK, Giatti S, Aielo AN, et al. OSA, short sleep duration, and their interactions with sleepiness and cardiometabolic risk factors in adults: the ELSA-Brasil study. Chest. 2019;155(6):1190\u20138.","journal-title":"Chest."},{"issue":"16","key":"1106_CR52","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1136\/heartjnl-2014-307276","volume":"101","author":"LE Costa","year":"2015","unstructured":"Costa LE, Uch\u00f4a CH, Harmon RR, Bortolotto LA, Lorenzi-Filho G, Drager LF. Potential underdiagnosis of obstructive sleep apnoea in the cardiology outpatient setting. Heart. 2015;101(16):1288\u201392.","journal-title":"Heart."},{"issue":"8","key":"1106_CR53","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.amjcard.2009.12.017","volume":"105","author":"LF Drager","year":"2010","unstructured":"Drager LF, Genta PR, Pedrosa RP, Nerbass FB, Gonzaga CC, Krieger EM, et al. Characteristics and predictors of obstructive sleep apnea in patients with systemic hypertension. Am J Cardiol. 2010;105(8):1135\u20139.","journal-title":"Am J Cardiol"},{"issue":"12","key":"1106_CR54","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1097\/00004872-200112000-00022","volume":"19","author":"AG Logan","year":"2001","unstructured":"Logan AG, Perlikowski SM, Mente A, Tisler A, Tkacova R, Niroumand M, et al. High prevalence of unrecognized sleep apnoea in drug-resistant hypertension. J Hypertens. 2001;19(12):2271\u20137.","journal-title":"J Hypertens"},{"issue":"5","key":"1106_CR55","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1378\/chest.06-2703","volume":"131","author":"LF Drager","year":"2007","unstructured":"Drager LF, Bortolotto LA, Figueiredo AC, Silva BC, Krieger EM, Lorenzi-Filho G. Obstructive sleep apnea, hypertension, and their interaction on arterial stiffness and heart remodeling. Chest. 2007;131(5):1379\u201386.","journal-title":"Chest."},{"issue":"2","key":"1106_CR56","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1161\/HYPERTENSIONAHA.118.10825","volume":"72","author":"F Fatureto-Borges","year":"2018","unstructured":"Fatureto-Borges F, Jenner R, Costa-Hong V, Lopes HF, Teixeira SH, Marum E, et al. Does obstructive sleep apnea influence blood pressure and arterial stiffness in response to antihypertensive treatment? Hypertension. 2018;72(2):399\u2013407.","journal-title":"Hypertension."},{"issue":"9","key":"1106_CR57","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1111\/jch.13008","volume":"19","author":"R Jenner","year":"2017","unstructured":"Jenner R, Fatureto-Borges F, Costa-Hong V, Lopes HF, Teixeira SH, Marum E, et al. Association of obstructive sleep apnea with arterial stiffness and nondipping blood pressure in patients with hypertension. J Clin Hypertens (Greenwich). 2017;19(9):910\u20138.","journal-title":"J Clin Hypertens (Greenwich)"},{"issue":"4","key":"1106_CR58","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1161\/HYPERTENSIONAHA.118.11525","volume":"72","author":"DC Genta-Pereira","year":"2018","unstructured":"Genta-Pereira DC, Furlan SF, Omote DQ, Giorgi DMA, Bortolotto LA, Lorenzi-Filho G, et al. Nondipping blood pressure patterns predict obstructive sleep apnea in patients undergoing ambulatory blood pressure monitoring. Hypertension. 2018;72(4):979\u201385.","journal-title":"Hypertension."},{"issue":"2","key":"1106_CR59","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1161\/HYPERTENSIONAHA.106.085175","volume":"50","author":"LA Bazzano","year":"2007","unstructured":"Bazzano LA, Khan Z, Reynolds K, He J. Effect of nocturnal nasal continuous positive airway pressure on blood pressure in obstructive sleep apnea. Hypertension. 2007;50(2):417\u201323.","journal-title":"Hypertension."},{"issue":"8","key":"1106_CR60","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1001\/archinte.167.8.757","volume":"167","author":"P Haentjens","year":"2007","unstructured":"Haentjens P, Van Meerhaeghe A, Moscariello A, De Weerdt S, Poppe K, Dupont A, et al. The impact of continuous positive airway pressure on blood pressure in patients with obstructive sleep apnea syndrome: evidence from a meta-analysis of placebo-controlled randomized trials. Arch Intern Med. 2007;167(8):757\u201364.","journal-title":"Arch Intern Med"},{"issue":"4","key":"1106_CR61","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1378\/chest.13-1115","volume":"145","author":"C Fava","year":"2014","unstructured":"Fava C, Dorigoni S, Dalle Vedove F, Danese E, Montagnana M, Guidi GC, et al. Effect of CPAP on blood pressure in patients with OSA\/hypopnea a systematic review and meta-analysis. Chest. 2014;145(4):762\u201371.","journal-title":"Chest."},{"key":"1106_CR62","first-page":"43","volume":"9","author":"F Fatureto-Borges","year":"2016","unstructured":"Fatureto-Borges F, Lorenzi-Filho G, Drager LF. Effectiveness of continuous positive airway pressure in lowering blood pressure in patients with obstructive sleep apnea: a critical review of the literature. Integr Blood Press Control. 2016;9:43\u20137.","journal-title":"Integr Blood Press Control"},{"issue":"5","key":"1106_CR63","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1378\/chest.13-0085","volume":"144","author":"RP Pedrosa","year":"2013","unstructured":"Pedrosa RP, Drager LF, de Paula LKG, Amaro ACS, Bortolotto LA, Lorenzi-Filho G. Effects of OSA treatment on BP in patients with resistant hypertension: a randomized trial. Chest. 2013;144(5):1487\u201394.","journal-title":"Chest."},{"issue":"22","key":"1106_CR64","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1001\/jama.2013.281250","volume":"310","author":"MA Mart\u00ednez-Garc\u00eda","year":"2013","unstructured":"Mart\u00ednez-Garc\u00eda MA, Capote F, Campos-Rodr\u00edguez F, Lloberes P, D\u00edaz de Atauri MJ, Somoza M, et al. Spanish Sleep Network. Effect of CPAP on blood pressure in patients with obstructive sleep apnea and resistant hypertension: the HIPARCO randomized clinical trial. JAMA. 2013;310(22):2407\u201315.","journal-title":"JAMA."},{"issue":"3","key":"1106_CR65","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1164\/rccm.201403-0479LE","volume":"190","author":"AC de Oliveira","year":"2014","unstructured":"de Oliveira AC, Martinez D, Massierer D, Gus M, Gon\u00e7alves SC, Ghizzoni F, et al. The antihypertensive effect of positive airway pressure on resistant hypertension of patients with obstructive sleep apnea: a randomized, double-blind, clinical trial. Am J Respir Crit Care Med. 2014;190(3):345\u20137.","journal-title":"Am J Respir Crit Care Med"},{"issue":"9","key":"1106_CR66","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.jacc.2015.06.1315","volume":"66","author":"M Sanches-De-La-Torre","year":"2015","unstructured":"Sanches-De-La-Torre M, Khalyfa A, Sanches-De-La-Torre A, Martinez-Alonso M, Martinez-Garcia MA, Barcel A, et al. Precision medicine in patients with resistant hypertension and obstructive sleep apnea blood pressure response to continuous positive airway pressure treatment. J Am Coll Cardiol. 2015;66(9):1023\u201332.","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"1106_CR67","doi-asserted-by":"crossref","first-page":"298","DOI":"10.4070\/kcj.2018.0433","volume":"49","author":"W Alkashkari","year":"2019","unstructured":"Alkashkari W, Albugami S, Hijazi ZM. Management of coarctation of the aorta in adult patients: state of the art. Korean Circ J. 2019;49(4):298\u2013313.","journal-title":"Korean Circ J"},{"key":"1106_CR68","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.jpeds.2008.05.059","volume":"153","author":"MD Reller","year":"2008","unstructured":"Reller MD, Strickland MJ, Riehle-Colarusso T, Mahle WT, Correa A. Prevalence of congenital heart defects in metropolitan Atlanta, 1998\u20132005. J Pediatr. 2008;153:807\u201313.","journal-title":"J Pediatr"},{"issue":"6","key":"1106_CR69","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s11886-005-0060-0","volume":"7","author":"PS Rao","year":"2005","unstructured":"Rao PS. Coarctation of the aorta. Curr Cardiol Rep. 2005;7(6):425\u201334.","journal-title":"Curr Cardiol Rep"},{"issue":"6","key":"1106_CR70","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1016\/j.ijcard.2012.09.084","volume":"167","author":"C Canniffe","year":"2013","unstructured":"Canniffe C, Ou P, Walsh K, Bonnet D, Celermajer D. Hypertension after repair of aortic coarctation--a systematic review. Int J Cardiol. 2013 Sep 10;167(6):2456\u201361.","journal-title":"Int J Cardiol"},{"issue":"Pt A","key":"1106_CR71","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ejphar.2015.06.027","volume":"763","author":"A Grossman","year":"2015","unstructured":"Grossman A, Messerli FH, Grossman E. Drug induced hypertension--an unappreciated cause of secondary hypertension. Eur J Pharmacol. 2015;763(Pt A):15\u201322.","journal-title":"Eur J Pharmacol"},{"issue":"8","key":"1106_CR72","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s11906-018-0871-1","volume":"20","author":"S Caletti","year":"2018","unstructured":"Caletti S, Paini A, Coschignano MA, De Ciuceis C, Nardin M, Zulli R, et al. Management of VEGF-targeted therapy-induced hypertension. Curr Hypertens Rep. 2018 Jun 29;20(8):68.","journal-title":"Curr Hypertens Rep"},{"issue":"1","key":"1106_CR73","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1056\/NEJMoa1614362","volume":"377","author":"A Afshin","year":"2017","unstructured":"GBD 2015 Obesity Collaborators, Afshin A, Forouzanfar MH, Reitsma MB, Sur P, Estep K, et al. Health effects of overweight and obesity in 195 countries over 25 years. N Engl J Med. 2017;377(1):13\u201327.","journal-title":"N Engl J Med."},{"issue":"2","key":"1106_CR74","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s11906-020-1016-x","volume":"22","author":"Z Wang","year":"2020","unstructured":"Wang Z, do Carmo JM, da Silva AA, Fu Y, Hall JE. Mechanisms of synergistic interactions of diabetes and hypertension in chronic kidney disease: role of mitochondrial dysfunction and ER stress. Curr Hypertens Rep. 2020;22(2):15.","journal-title":"Curr Hypertens Rep"},{"issue":"6","key":"1106_CR75","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/s11906-019-0951-x","volume":"21","author":"AA da Silva","year":"2019","unstructured":"da Silva AA, do Carmo JM, Wang Z, Hall JE. Melanocortin-4 receptors and sympathetic nervous system activation in hypertension. Curr Hypertens Rep. 2019;21(6):46.","journal-title":"Curr Hypertens Rep"},{"issue":"11","key":"1106_CR76","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1007\/s11906-018-0894-7","volume":"20","author":"E Das","year":"2018","unstructured":"Das E, Moon JH, Lee JH, Thakkar N, Pausova Z, Sung HK. Adipose tissue and modulation of hypertension. Curr Hypertens Rep. 2018 Sep 18;20(11):96.","journal-title":"Curr Hypertens Rep"},{"issue":"7","key":"1106_CR77","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s11906-016-0658-1","volume":"18","author":"JM do Carmo","year":"2016","unstructured":"do Carmo JM, da Silva AA, Wang Z, Fang T, Aberdein N, de Lara Rodriguez CE, et al. Obesity-induced hypertension: brain signaling pathways. Curr Hypertens Rep. 2016;18(7):58.","journal-title":"Curr Hypertens Rep"},{"issue":"2","key":"1106_CR78","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1161\/01.HYP.0000174243.39897.6c","volume":"46","author":"G Grassi","year":"2005","unstructured":"Grassi G, Facchini A, Trevano FQ, Dell\u2019Oro R, Arenare F, Tana F, et al. Obstructive sleep apnea-dependent and -independent adrenergic activation in obesity. Hypertension. 2005;46(2):321\u20135.","journal-title":"Hypertension."},{"issue":"6","key":"1106_CR79","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1038\/nrendo.2014.44","volume":"10","author":"VG DeMarco","year":"2014","unstructured":"DeMarco VG, Aroor AR, Sowers JR. The pathophysiology of hypertension in patients with obesity. Nat Rev Endocrinol. 2014;10(6):364\u201376.","journal-title":"Nat Rev Endocrinol"},{"issue":"3","key":"1106_CR80","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1001\/jama.2017.21055","volume":"319","author":"GS Jakobsen","year":"2018","unstructured":"Jakobsen GS, Sm\u00e5stuen MC, Sandbu R, Nordstrand N, Hofs\u00f8 D, Lindberg M, et al. Association of bariatric surgery vs medical obesity treatment with long-term medical complications and obesity-related comorbidities. JAMA. 2018;319(3):291\u2013301.","journal-title":"JAMA."},{"issue":"12","key":"1106_CR81","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1056\/NEJMoa1700459","volume":"377","author":"TD Adams","year":"2017","unstructured":"Adams TD, Davidson LE, Litwin SE, Kim J, Kolotkin RL, Nanjee MN, et al. Weight and metabolic outcomes 12 years after gastric bypass. Weight and metabolic outcomes 12 years after gastric bypass. N Engl J Med. 2017;377(12):1143\u201355.","journal-title":"N Engl J Med"},{"issue":"11","key":"1106_CR82","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1161\/CIRCULATIONAHA.117.032130","volume":"137","author":"CA Schiavon","year":"2018","unstructured":"Schiavon CA, Bersch-Ferreira AC, Santucci EV, et al. Effects of bariatric surgery in obese patients with hypertension: The GATEWAY Randomized Trial (Gastric Bypass to Treat Obese Patients With Steady Hypertension). Circulation. 2018;137(11):1132\u201342 Erratum in: Circulation. 2019;140(14):e718.","journal-title":"Circulation"},{"issue":"3","key":"1106_CR83","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1161\/HYPERTENSIONAHA.118.12290","volume":"73","author":"CA Schiavon","year":"2019","unstructured":"Schiavon CA, Ikeoka D, Santucci EV, Santos RN, Damiani LP, Bueno PT, et al. Effects of bariatric surgery versus medical therapy on the 24-hour ambulatory blood pressure and the prevalence of resistant hypertension: the GATEWAY randomised clinical trial. Hypertension. 2019;73(3):571\u20137.","journal-title":"Hypertension."}],"container-title":["Current Hypertension Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11906-020-01106-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11906-020-01106-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11906-020-01106-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T13:39:21Z","timestamp":1669383561000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11906-020-01106-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,29]]},"references-count":83,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1106"],"URL":"https:\/\/doi.org\/10.1007\/s11906-020-01106-5","relation":{},"ISSN":["1522-6417","1534-3111"],"issn-type":[{"value":"1522-6417","type":"print"},{"value":"1534-3111","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,29]]},"assertion":[{"value":"1 August 2020","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2020","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethics Guidelines"}},{"value":"The authors declare no conflicts of interest relevant to this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}],"article-number":"101"}}